A Biocompatible Gadolinium-Based Amino Acid Copolymer Contrast Agent for Magnetic Resonance Imaging

You-yang ZHAN,Rong XUE,Yun-long ZHU,Xiao-jing LI,Feng-kui PEI,Jiang-hua FENG
DOI: https://doi.org/10.11938/cjmr20160413
2016-01-01
Abstract:A macromolecular gadolinium complex was prepared as a magnetic resonance imaging (MRI) contrast agent. An ethlendiamine-modified aspartic acid-valine copolymer was synthesized, conjugated with DOTA, and then chelated with Gd3+ (AI-EDA-DOTA-Gd).T1-relaxivity of the agent (i.e., 12.6 mmol–1×L×s–1) was 2.2 times that of Gd-DOTA (i.e., 5.8 mmol–1×L×s–1). Hemolytic tests showed that the macromolecular contrast agent had good blood compatibility. Histological results demonstrated low toxicity of the agentin vivo. MRI experiments on rats demonstrated a prominent enhancement in liver after AI-EDA-DOTA-Gd injection, which persisted longer than that obtained by Gd-DOTA injection. The mean percentage enhancement in liver parenchyma was (55.1±5.7)% at 30~70 min after injection.
What problem does this paper attempt to address?